These findings suggest that the AD pathology present in 3D human neuronal systems (FAD and UBB+1) is dependent on the level of UBB+1 and that silencing UBB+1 expression is an effective approach to hinder AD development. This evidence concerns the gene UBB and Alzheimer disease.